Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Cattaneo

Showing results (11-20 of 263) with videos related to

Pageof 27
Sort By:
European Heart Journal|June 26, 2007
Laboratory detection of 'aspirin resistance': what test should we use (if any)?Marco Cattaneo
European Heart Journal. Cardiovascular Pharmacotherapy|July 17, 2025
Sex-related differences in platelet aggregationMarco Cattaneo
Haematologica|March 27, 2025
Pseudothrombocytopenia and other conditions associated with spuriously low platelet countsMarco Cattaneo
Thrombosis Research|January 26, 2011
Resistance to anti-platelet agentsMarco Cattaneo
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Tailored treatment with clopidogrel based on the results of platelet function tests should not be implemented, in the absence of clear indications on the methodology to be used]Marco Cattaneo
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
Is hyperhomocysteinemia an important risk factor of cardiovascular disease?Marco Cattaneo
Clinical Chemistry|April 30, 2013
CommentaryMarco Cattaneo
The New England Journal of Medicine|January 6, 2010
Ticagrelor versus clopidogrel in acute coronary syndromesMarco Cattaneo
European Heart Journal|March 30, 2006
P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agentsMarco Cattaneo
Seminars in Thrombosis and Hemostasis|October 7, 2006
Hyperhomocysteinemia and venous thromboembolismMarco Cattaneo
Pageof 27

Showing results (11-20 of 263) with videos related to

Sort By:
Pageof 27
European Heart Journal|June 26, 2007
Laboratory detection of 'aspirin resistance': what test should we use (if any)?Marco Cattaneo
European Heart Journal. Cardiovascular Pharmacotherapy|July 17, 2025
Sex-related differences in platelet aggregationMarco Cattaneo
Haematologica|March 27, 2025
Pseudothrombocytopenia and other conditions associated with spuriously low platelet countsMarco Cattaneo
Thrombosis Research|January 26, 2011
Resistance to anti-platelet agentsMarco Cattaneo
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Tailored treatment with clopidogrel based on the results of platelet function tests should not be implemented, in the absence of clear indications on the methodology to be used]Marco Cattaneo
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
Is hyperhomocysteinemia an important risk factor of cardiovascular disease?Marco Cattaneo
Clinical Chemistry|April 30, 2013
CommentaryMarco Cattaneo
The New England Journal of Medicine|January 6, 2010
Ticagrelor versus clopidogrel in acute coronary syndromesMarco Cattaneo
European Heart Journal|March 30, 2006
P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agentsMarco Cattaneo
Seminars in Thrombosis and Hemostasis|October 7, 2006
Hyperhomocysteinemia and venous thromboembolismMarco Cattaneo
Pageof 27